Literature DB >> 9819375

Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.

K R Cooke1, G R Hill, J M Crawford, D Bungard, Y S Brinson, J Delmonte, J L Ferrara.   

Abstract

Donor T cell responses to host alloantigen are known predictors for graft-versus-host disease (GVHD); however, the effect of donor responsiveness to an inflammatory stimulus such as lipopolysaccharide (LPS) on GVHD severity has not been investigated. To examine this, we used mouse strains that differ in their sensitivity to LPS as donors in an experimental bone marrow transplant (BMT) system. Lethally irradiated (C3FeB6)F1 hosts received BMT from either LPS-sensitive (LPS-s) C3Heb/Fej, or LPS-resistant (LPS-r) C3H/ Hej donors. Mice receiving LPS-r BMT developed significantly less GVHD as measured by mortality and clinical score compared with recipients of LPS-s BMT, a finding that was associated with significant decreases in intestinal histopathology and serum LPS and TNF-alpha levels. When donor T cell responses to host antigens were measured, no differences in proliferation, serum IFN-gamma levels, splenic T cell expansion, or CTL activity were observed after LPS-r or LPS-s BMT. Systemic neutralization of TNF-alpha from day -2 to +6 resulted in decreased intestinal pathology, and serum LPS levels and increased survival after BMT compared with control mice receiving Ig. We conclude that donor resistance to endotoxin reduces the development of acute GVHD by attenuating early intestinal damage mediated by TNFalpha. These data suggest that the responsiveness of donor accessory cells to LPS may be an important risk factor for acute GVHD severity independent of T cell responses to host antigens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819375      PMCID: PMC509139          DOI: 10.1172/JCI4285

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  65 in total

Review 1.  Lipopolysaccharide nonresponder cells: the C3H/HeJ defect.

Authors:  B M Sultzer; R Castagna; J Bandekar; P Wong
Journal:  Immunobiology       Date:  1993-04       Impact factor: 3.144

2.  E5531, a pure endotoxin antagonist of high potency.

Authors:  W J Christ; O Asano; A L Robidoux; M Perez; Y Wang; G R Dubuc; W E Gavin; L D Hawkins; P D McGuinness; M A Mullarkey
Journal:  Science       Date:  1995-04-07       Impact factor: 47.728

3.  Antibodies against CD14 protect primates from endotoxin-induced shock.

Authors:  D J Leturcq; A M Moriarty; G Talbott; R K Winn; T R Martin; R J Ulevitch
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

Review 4.  The role of cytokines in acute graft-versus-host disease.

Authors:  G R Hill; W Krenger; J L Ferrara
Journal:  Cytokines Cell Mol Ther       Date:  1997-12

5.  Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.

Authors:  W Krenger; K M Snyder; J C Byon; G Falzarano; J L Ferrara
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

6.  Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide).

Authors:  A Haziot; G W Rong; X Y Lin; J Silver; S M Goyert
Journal:  J Immunol       Date:  1995-06-15       Impact factor: 5.422

7.  Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F).

Authors:  E Holler; H J Kolb; J Mittermüller; M Kaul; G Ledderose; T Duell; B Seeber; M Schleuning; R Hintermeier-Knabe; B Ertl
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

8.  Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin.

Authors:  G Eissner; F Kohlhuber; M Grell; M Ueffing; P Scheurich; A Hieke; G Multhoff; G W Bornkamm; E Holler
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

9.  TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD.

Authors:  M Remberger; O Ringden; L Markling
Journal:  Bone Marrow Transplant       Date:  1995-01       Impact factor: 5.483

10.  Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.

Authors:  M Y Braun; B Lowin; L French; H Acha-Orbea; J Tschopp
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  128 in total

Review 1.  A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.

Authors:  O Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Novel role for surfactant protein A in gastrointestinal graft-versus-host disease.

Authors:  Kymberly M Gowdy; Diana M Cardona; Julia L Nugent; Charles Giamberardino; Joseph M Thomas; Sambuddho Mukherjee; Sambudho Mukherjee; Tereza Martinu; W Michael Foster; Scott E Plevy; Amy M Pastva; Jo Rae Wright; Scott M Palmer
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

Review 3.  Tight junction pore and leak pathways: a dynamic duo.

Authors:  Le Shen; Christopher R Weber; David R Raleigh; Dan Yu; Jerrold R Turner
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

4.  Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.

Authors:  Christine V Kinnier; Tereza Martinu; Kymberly M Gowdy; Julia L Nugent; Francine L Kelly; Scott M Palmer
Journal:  Transpl Immunol       Date:  2010-11-09       Impact factor: 1.708

Review 5.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

6.  Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.

Authors:  Matin M Imanguli; Jane C Atkinson; Kristen E Harvey; Gerard T Hoehn; Ok Hee Ryu; Tianxia Wu; Albert Kingman; A John Barrett; Michael R Bishop; Richard W Childs; Daniel H Fowler; Steven Z Pavletic; Thomas C Hart
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

7.  Siglec-G represses DAMP-mediated effects on T cells.

Authors:  Tomomi Toubai; Corinne Rossi; Katherine Oravecz-Wilson; Cynthia Zajac; Chen Liu; Thomas Braun; Hideaki Fujiwara; Julia Wu; Yaping Sun; Stuart Brabbs; Hiroya Tamaki; John Magenau; Pang Zheng; Yang Liu; Pavan Reddy
Journal:  JCI Insight       Date:  2017-07-20

8.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

9.  Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.

Authors:  Stavros Garantziotis; Scott M Palmer; Laurie D Snyder; Tonya Ganous; Benny J Chen; Tie Wang; Donald N Cook; David A Schwartz
Journal:  Transplantation       Date:  2007-10-27       Impact factor: 4.939

Review 10.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.